Everence Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Everence Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,169	Closed	-$147K	–	882
2026 Q1	$147K	Buy	+10,169	New	+$146K	0.01%	773

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Everence Capital Management's FOLD Position: Q2 2026 in Review

Everence Capital Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 10,169 shares — an estimated $147K sold.

Everence Capital Management first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $147K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Everence Capital Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Everence Capital Management sold 10,169 Amicus Therapeutics shares in Q2 2026, an estimated $147K.
Everence Capital Management first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
Everence Capital Management's Amicus Therapeutics position peaked at $147K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.